1 VEMLIDY (TENOFOVIR ALAFENAMIDE) | 50 of 250 | 860 prescriptions Less than 1% of all prescriptions | 380 | 170 patients 11% of all patients | < 11 | |
2 URSODIOL | 90 of 760 | 490 prescriptions Less than 1% of all prescriptions | | 110 patients 7% of all patients | < 11 | |
3 LACTULOSE | 180 of 1620 | 490 prescriptions Less than 1% of all prescriptions | 380 | 240 patients 15% of all patients | < 11 | |
4 XIFAXAN (RIFAXIMIN) | 70 of 490 | 440 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
5 ENTECAVIR | 50 of 230 | 370 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
6 OMEPRAZOLE | 2850 of 1,6870 | 270 prescriptions Less than 1% of all prescriptions | 160 | 110 patients 7% of all patients | < 11 | |
7 EPCLUSA (SOFOSBUVIR/VELPATASVIR) | 10 of 40 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 PANTOPRAZOLE SODIUM | 1770 of 1,4400 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
9 RANITIDINE HCL | 1420 of 1,0050 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 NADOLOL | 110 of 470 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
11 RIBAVIRIN | 10 of 20 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 MAVYRET (GLECAPREVIR/PIBRENTASVIR) | 30 of 90 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 ESOMEPRAZOLE MAGNESIUM | 850 of 5350 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 FUROSEMIDE | 1970 of 1,5480 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
15 POLYETHYLENE GLYCOL 3350 | 930 of 5140 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 PEG-3350 AND ELECTROLYTES (PEG3350/SOD SULF,BICARB,CL/KCL) | 80 of 80 | 110 prescriptions Less than 1% of all prescriptions | | 110 patients 7% of all patients | < 11 | |
17 GAVILYTE-G (PEG3350/SOD SULF,BICARB,CL/KCL) | 280 of 460 | 260 prescriptions Less than 1% of all prescriptions | | 260 patients 16% of all patients | < 11 | |